⌘K
Loading ticker…
Biomea Fusion, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Biomea Fusion, Inc. Common Stock (BMEA) has a 3-month relative strength percentile of 34 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.4%, relative volume 1.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
34 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
BMEA is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $974K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMEA Jan avg: 8.88% median: 10.33% win: 75% σ: 14.22% n: 4 2022-04-12 → 2026-05-29 | BMEA Feb avg: 5.78% median: 9.56% win: 50% σ: 29.12% n: 4 2022-04-12 → 2026-05-29 | BMEA Mar avg: 28.08% median: -1.45% win: 50% σ: 77.27% n: 4 2022-04-12 → 2026-05-29 | BMEA Apr avg: -15.97% median: -11.11% win: 0% σ: 14.47% n: 5 2022-04-12 → 2026-05-29 | BMEA May avg: 13.25% median: 1.47% win: 60% σ: 42.54% n: 5 2022-04-12 → 2026-05-29 | BMEA Jun avg: 12.66% median: -5.18% win: 50% σ: 78.50% n: 4 2022-04-12 → 2026-05-29 (current) | BMEA Jul avg: 1.46% median: -3.21% win: 50% σ: 15.83% n: 4 2022-04-12 → 2026-05-29 | BMEA Aug avg: 8.34% median: 12.98% win: 75% σ: 23.68% n: 4 2022-04-12 → 2026-05-29 | BMEA Sep avg: 2.00% median: -5.68% win: 50% σ: 25.75% n: 4 2022-04-12 → 2026-05-29 | BMEA Oct avg: -13.29% median: -16.48% win: 25% σ: 20.26% n: 4 2022-04-12 → 2026-05-29 | BMEA Nov avg: -7.44% median: -21.29% win: 25% σ: 37.15% n: 4 2022-04-12 → 2026-05-29 | BMEA Dec avg: -4.76% median: 5.06% win: 50% σ: 29.23% n: 4 2022-04-12 → 2026-05-29 |